RafaelBejarMDPhD

PubMed

• 4 citations
  Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Cons...
  Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami Komrokji, Mina L Xu, Omar Abdel-Wahab, Justin Taylor, David P Steensma, Daniel ...> ;Blood Reviews. 2023 Nov 1
• Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.
  Edward J Gorak, Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M Foran, Jane Jijun Liu, Rafael Bejar, Steven D Gore, Steven H Kroft, Alexandra Harrington...> ;Blood Advances. 2023 Oct 24
• Newly revised 2023 MDS response criteria.
  Rafael Bejar> ;Blood. 2023 Apr 27
• 3 citations
  Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions.
  Amy E DeZern, Johannes B Goll, R Coleman Lindsley, Rafael Bejar, Steffanie H Wilson, Donnie Hebert, Joachim Deeg, Ling Zhang, Steven Gore, Tareq Al Baghdadi, Jaroslaw ...> ;Blood Advances. 2023 Jul 25
• 6 citations
  Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1International Workshop on MDS (iwMDS) Of t...
  Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M Brunner, Rena Buckstein, Hetty E Carraway, Jane E Churpek, Naval G Daver, ...> ;Blood Reviews. 2023 Jul 1
• How can we incorporate molecular data into the IPSS?
  Rafael Bejar> ;Best Practice & Research. Clinical Haematology. 2022 Dec 1
• 2 citations
  How can we improve response assessments in MDS? Strategies to improve response assessment in MDS treatment paradigms.
  Rafael Bejar> ;Best Practice & Research. Clinical Haematology. 2022 Dec 1
• 1 citations
  Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms.
  Mrinal M Patnaik, Amer M Zeidan, Eric Padron, Uwe Platzbecker, David A Sallman, Amy E DeZern, Rafael Bejar, Mikkael Sekeres, Justin Taylor, Richard F Little, Jan P Bew...> ;Leukemia. 2022 Dec 1
• 13 citations
  Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.
  Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M ...> ;Leukemia. 2022 Dec 1
• 4 citations
  An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
  Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, Michael R Savona, Mina L Xu, Zhuoer Xie, Justin Taylor, Daniel Starczynowski, Guillermo F Sanz, David A Sallman, Vale...> ;Blood Advances. 2023 Jun 27
• 2 citations
  RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS.
  Yi-Jou Huang, Jia-Yu Chen, Ming Yan, Amanda G Davis, Sayuri Miyauchi, Liang Chen, Yajing Hao, Sigrid Katz, Rafael Bejar, Omar Abdel-Wahab, Xiang-Dong Fu, Dong-Er Zhang> ;Blood Advances. 2022 Dec 13
• Can Lower-Risk MDS Achieve High Reward with Hypomethylating Agent Therapy?
  Bejar, R.> ;NEJM Evidence. 2022 Oct 1
• 57 citations
  Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
  Eric J Duncavage, Adam Bagg, Robert P Hasserjian, Courtney D DiNardo, Lucy A Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro M Vannucchi, Keyu...> ;Blood. 2022 Nov 24
• 3 citations
  Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes.
  Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, Hannah Newman, Virginia Volpe, Christopher Letson, Markus Ball, Anthony M Hunter, Maria E Balasis, Traci Kr...> ;Blood Cancer Discovery. 2022 Nov 2
• 17 citations
  DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages.
  Isidoro Cobo, Tiffany N Tanaka, Kailash Chandra Mangalhara, Addison Lana, Calvin Yeang, Claudia Han, Johannes Schlachetzki, Jean Challcombe, Bethany R Fixsen, Mashito ...> ;Immunity. 2022 Aug 9
• 6 citations
  Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts.
  Vera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, Natthakan Thongon, Guillermo Montalban-Bravo, Hui Yang, Scott A Peslak, Feng Wang, Pamela Acha, Francesc Sole, Pamela ...> ;Blood Cancer Discovery. 2022 Nov 2
• 988 citations
  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
  Khoury, J., Solary, E., Abla, O., Akkari, Y., Alaggio, R., Apperley, J., Bejar, R., Berti, E., Busque, L., Chan, J., Chen, W., Chen, X., Chng, W., Choi, J., Colmenero,...> ;Leukemia. 2022 Jul 1
• 40 citations
  Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
  Bernard, E., Tuechler, H., Greenberg, P., Hasserjian, R., Arango Ossa, J., Nannya, Y., Devlin, S., Creignou, M., Pinel, P., Monnier, L., Gundem, G., Medina-Martinez, J...> ;NEJM Evidence. 2022 Jul 1
• Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.
  Tariq I Mughal, Naveen Pemmaraju, Rafael Bejar, Robert P Gale, Prithviraj Bose, Jean-Jacques Kiladjian, Josef Prchal, Daniel Royston, Daniel Pollyea, Peter Valent, Tim...> ;Hematological Oncology. 2022 Oct 1
• Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning.
  David A Sallman, Rafael Bejar, Guillermo Montalban-Bravo, Sandra E Kurtin, Alan F List, Guillermo Garcia-Manero, Stephen D Nimer, Casey L O'Connell, Dale Schaar, Janic...> ;Leukemia Research Reports. 2022 Jan 1
• How do molecular aberrations guide therapy in MDS
  Rafael Bejar> ;Best Practice & Research. Clinical Haematology. 2021 Oct 23
• 7 citations
  Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30.
  Antoine Regnault, Farrah Pompilus, Anna Ciesluk, Flora Mazerolle, Rafael Bejar, Robert J. Fram, Douglas V. Faller, Patrick Marquis, Jill A Bell> ;Journal of Patient-Reported Outcomes. 2021 Jul 20
• 3 citations
  Indolent T-cell prolymphocytic leukemia with no expression of surface T-cell receptors or surface CD3.
  Huan-You Wang, Sarah S. Murray, Rafael Bejar> ;International Journal of Laboratory Hematology. 2021 Apr 14
• 1 citations
  Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
  Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca ...> ;Nature Medicine. 2021 May 1
• 1 citations
  Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
  Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca ...> ;Nature Medicine. 2021 Mar 1
• Join now to see all

Abstracts/Posters

• TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes
  Rafael Bejar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study
  Rafael Bejar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients with Myelodysplastic Syndromes (MDS): Results of a L... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of MDS 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Hippo Kinase Inactivation Contributes to Del(20q) Malignancies and Cooperates with JAK2-V617F to Promote Myelofibrosis in Mice 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018